Karabiber, E. Et Al. 2023. Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.. Tuberkuloz ve toraks , vol.71, no.3 , 236-249.

Karabiber, E., Atik, Ö., Tepetam, F. M., Ergan, B., İlki, A., Karakoç Aydıner, E., ... Özen, A. O.(2023). Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.. Tuberkuloz ve toraks , vol.71, no.3, 236-249.

Karabiber, Esra Et Al. "Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.," Tuberkuloz ve toraks , vol.71, no.3, 236-249, 2023

Karabiber, Esra Et Al. "Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.." Tuberkuloz ve toraks , vol.71, no.3, pp.236-249, 2023

Karabiber, E. Et Al. (2023) . "Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.." Tuberkuloz ve toraks , vol.71, no.3, pp.236-249.

@article{article, author={Esra Karabiber Et Al. }, title={Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.}, journal={Tuberkuloz ve toraks}, year=2023, pages={236-249} }